Achieving Impact in the Clinic with Innovative Medicine

Achieving Impact in the Clinic with Innovative Medicine: an Entrepreneurial GW Academic Clinician’s Experience

An in-person discussion with lunch

Friday November 4, 2022

12:00-1:00 pm

227 Ross Hall

Lakhmir ‘Mink’ Chawla, MD

Chief Medical Officer, Silver Creek Pharmaceuticals

Former Professor of Medicine, The George Washington University

Former Chief Medical Officer, La Jolla Pharmaceutical Co.

While practicing critical care medicine with the GW Medical Faculty Associates, former GW professor, Lakhmir ‘Mink’ Chawla, MD, invented methods of using angiotensin II to increase blood pressure in adults with septic or other distributive shock. He then led the development of GIAPREZA (angiotensin II) through FDA and EMA approval as CMO of GW licensee, La Jolla Pharmaceutical Co.

Mink now visits GW to share critical actions and lessons learned he took that enabled his innovative treatment to reach patients across the country.

Quan Nguyen, JD, MS

Partner, Nguyen Tarbet, LLC

Attorney and angel investor, Quan Nguyen, JD, MS, supports universities, large and small businesses, investors and entrepreneurs in intellectual property matters. He helps obtain patents and execute due diligence for investments reliant on patent protection. He is also an active angel investor himself.

Quan will reinforce key legal implications of interest to medical innovators.

View the agenda on Eventbrite.

This event is presented thanks to support from Nguyen Tarbet LLC.